Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biohaven Ltd (BHVN)

Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,149,928
  • Shares Outstanding, K 88,258
  • Annual Sales, $ 0 K
  • Annual Income, $ -408,170 K
  • 60-Month Beta 1.26
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.75
Trade BHVN with:

Options Overview Details

View History
  • Implied Volatility 114.31% ( -1.65%)
  • Historical Volatility 74.06%
  • IV Percentile 86%
  • IV Rank 71.03%
  • IV High 141.17% on 07/25/23
  • IV Low 48.46% on 08/28/23
  • Put/Call Vol Ratio 1.94
  • Today's Volume 9,740
  • Volume Avg (30-Day) 1,800
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 20,740
  • Open Int (30-Day) 20,784

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.51
  • Number of Estimates 4
  • High Estimate -1.22
  • Low Estimate -1.95
  • Prior Year -1.32
  • Growth Rate Est. (year over year) -14.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.87 +5.37%
on 05/10/24
53.80 -33.66%
on 04/11/24
-15.37 (-30.10%)
since 04/10/24
3-Month
33.87 +5.37%
on 05/10/24
62.21 -42.63%
on 03/08/24
-12.86 (-26.49%)
since 02/09/24
52-Week
13.46 +165.16%
on 05/12/23
62.21 -42.63%
on 03/08/24
+21.36 (+149.06%)
since 05/10/23

Most Recent Stories

More News
Canada Jobs in Focus Next Week

Monday U.S. Featured Earnings Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (Q1) EPS of $3.66, ...

ESI.TO : 2.25 (-3.43%)
FTT.TO : 43.18 (-0.48%)
SU.TO : 54.79 (-0.25%)
VRTX : 422.78 (+0.90%)
MCHP : 91.50 (+0.02%)
PLTR : 20.60 (-2.55%)
DIS : 105.79 (-0.01%)
ANET : 314.03 (+6.07%)
TM : 218.78 (-3.72%)
UBER : 66.99 (-1.38%)
ABNB : 146.32 (-0.50%)
HMC : 33.78 (-0.47%)
Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek®

- Taldefgrobep is a novel myostatin inhibitor with the potential to be an important therapy for neuromuscular disorders and metabolic diseases including...

BHVN : 35.69 (-13.71%)
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...

BHVN : 35.69 (-13.71%)
Markets Today: Stocks Decline as Bond Yields Soar

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.61%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.76%. Stock index futures this morning are moderately lower, weighed...

ESM24 : 5,246.25s (+0.14%)
NQM24 : 18,255.00s (+0.22%)
MCK : 559.91 (+0.86%)
BHVN : 35.69 (-13.71%)
ABNB : 146.32 (-0.50%)
KLG : 21.77 (-1.94%)
HPQ : 29.72 (+0.24%)
DOW : 59.41 (-0.07%)
LYB : 101.37 (-0.26%)
FVRR : 23.52 (+4.95%)
DY : 150.57 (-0.31%)
PNT : 12.50 (+0.16%)
Biohaven Announces Pricing of $225 Million Public Offering of Common Shares

/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...

BHVN : 35.69 (-13.71%)
BIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES

/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...

BHVN : 35.69 (-13.71%)
Why Biohaven Stock Is Skyrocketing Today

Promising clinical trial data led investors to bid the stock up, adding to its solid year-to-date gain.

BHVN : 35.69 (-13.71%)
Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy

/PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and...

BHVN : 35.69 (-13.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN). Such investors are...

BHVN : 35.69 (-13.71%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN). Such investors are...

BHVN : 35.69 (-13.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut....

See More

Key Turning Points

3rd Resistance Point 47.30
2nd Resistance Point 44.25
1st Resistance Point 39.97
Last Price 35.69
1st Support Level 32.64
2nd Support Level 29.59
3rd Support Level 25.31

See More

52-Week High 62.21
Fibonacci 61.8% 43.59
Fibonacci 50% 37.83
Last Price 35.69
Fibonacci 38.2% 32.08
52-Week Low 13.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar